Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Long‐term prognosis of cerebral venous sinus thrombosis in childhood
2004
Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension
2011 StandoutNobel
Cerebral venous and sinus thrombosis
2004
Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis
2004
Breast cancer
2016 Standout
Vascular endothelin in hypertension
2005
Cerebral venous thrombosis: an update
2007 Standout
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
2006
Cancer to bone: a fatal attraction
2011 Standout
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
2010
Endothelin antagonism with bosentan: a review of potential applications
1999
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Long-term prognosis of cerebral venous sinus thrombosis in childhood
2004
Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients
2001
Cardiac hypertrophy in Aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure
2003
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
2009
Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis
2003
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
2009
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
2008
Bisphosphonates in breast cancer
2005
Endothelin antagonists
1999
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
Adjusting for multiple testing—when and how?
2001 Standout
Diabetes and Atherosclerosis
2002 Standout
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
2001 Standout
How were new medicines discovered?
2011 Standout
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia
2008
Signaling Pathways of Mechanotransduction in Arteriolar Endothelium and Smooth Muscle Cells in Hypertension
2002
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
The role of the endothelium in modulating vascular control in sepsis and related conditions
1999
New therapeutics that antagonize endothelin: promises and frustrations
2002
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Genomic instability — an evolving hallmark of cancer
2010 Standout
The endothelin axis: emerging role in cancer
2003
Cerebral venous thrombosis: an all or nothing disease?
2004
Endothelin: emerging role in diabetic vascular complications
1999
Multiple testing in clinical trials
1991
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial Function
1999
Ambrisentan, a Non‐peptide Endothelin Receptor Antagonist
2006
The cancer genome
2009 StandoutNature
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus
2002
Review: Update on Newer Antihypertensive Medicines and Interventions
2010
Bisphosphonates: Clinical Experience
2004
Short-Term Oral Endothelin-Receptor Antagonist Therapy in Conventionally Treated Patients With Symptomatic Severe Chronic Heart Failure
1998
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome
2005
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy
2001
Cerebral venous thrombosis: Update on clinical manifestations, diagnosis and management
2008
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Role of Endothelin in the Increased Vascular Tone of Patients With Essential Hypertension
1999
Endothelin Receptor Blockers in Cardiovascular Disease
2003
Plasma Endothelin-1, Cytokine, and Prostaglandin E2Levels in Sickle Cell Disease and Acute Vaso-Occlusive Sickle Crisis
1998
Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial
2005
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
2004 Standout
Mechanisms of FK 506–Induced Hypertension in the Rat
1999
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
2006
Natural history of cerebral vein thrombosis: a systematic review
2006
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
2008
Mechanistic studies of blood pressure in rats treated with a series of cholesteryl ester transfer protein inhibitors
2009
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
The effect of diabetes on endothelin, interleukin-8 and vascular endothelial growth factor-mediated angiogenesis in rats
2002
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
2006
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of M. Budde being referenced
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer
2004
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial
2004
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
2003
The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension
1998
Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis
2000
Multiple Test Procedures in Clinical Dose Finding Studies
1989
Safety of an intravenous (i.v.) dose of ibandronate followed by daily oral dosing in metastatic bone disease: Results of an open-label study
2004